UF College of Medicine Launches Pediatric Obesity Fellowship To Tackle National Epidemic
UF’s Pediatric Obesity Fellowship Training Program is paving the way for specialized training to address the growing need for obesity prevention and treatment.
UF Health Expert Discusses COVID-19 Booster Shots
Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
UF Health Researcher, Collaborators Discover Compounds That Might Boost Stroke Recovery
When a patient suffers a stroke, oxygen-starved brain cells begin dying within minutes. In these crucial moments, the brain produces a vital catalyst to protect itself and aid in recovery. That catalyst — an enzyme known as neurolysin — activates a cascade of chemical messengers that reduce cell damage, swelling and inflammation in the brain. Now, a University of Florida Health researcher and his collaborators at Texas Tech University and other universities have discovered two compounds that appear to make the brain-protecting enzyme even more effective.
Patients With Severe COVID-19 Twice As Likely To Require Future Hospitalizations for Other Illnesses
People who have recovered from a bout of severe COVID-19 may still have a reason for concern about their health. A new University of Florida study has found that patients who had a severe case of the disease were more than twice as likely as patients who had mild or moderate COVID-19 to need hospitalization again for health problems caused by COVID-19 complications.
UF Neurosurgery Chair Elected President of Congress of Neurological Surgeons
University of Florida neurosurgery chair Brian Hoh, M.D., MBA, has been elected the 2020-21 president of the Congress of Neurological Surgeons, one of the largest international neurosurgical societies, with over 9,800 members. Two other UF Health neurosurgeons, Daniel Hoh, M.D., and Maryam Rahman, M.D., also have been elected to leadership positions in the CNS: Daniel Hoh will serve […]
Five Questions for Michael S. Okun, M.D.
Michael S. Okun, M.D. is chair of Neurology, Adelaide Lackner professor, and executive director of the Norman Fixel Institute for Neurological Diseases at the University of Florida College of Medicine. He received his M.D. with honors from the University of Florida and, subsequently, was fellowship-trained at Emory University before establishing the movement disorders program at […]
Atsena Therapeutics Acquires Exclusive Rights to Gene Therapy for GUCY2D-Associated Leber Congenital Amaurosis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that it has acquired exclusive rights to a gene therapy targeting GUCY2D-associated Leber congenital amaurosis (LCA1), a genetic eye disease that affects the retina and is a leading cause of blindness […]
UF Neurologists Create a New Image of Parkinson Disease
An outdated sketch from 1886 by Sir William Richard Gowers remains among the most used and viewed depictions of Parkinson disease, despite great advancements in the understanding of the neurological disorder. Now, UF neurologists Melissa Armstrong, M.D. and Michael S. Okun, M.D. have worked with a medical illustrator to create a new, more diverse representation of who is affected by […]
Harnessing Genome Editing for COVID-19 Drug Discovery
A University of Florida research team is harnessing the power of genomic editing to illuminate druggable targets in human cells for the fight against COVID-19. By taking advantage of high-containment labs in UF’s Emerging Pathogens Institute—especially designed for studying highly contagious and virulent pathogens—the team is using CRISPR genome editing techniques to screen human cell […]
Ticagrelor Alone, Without Aspirin, Shows Benefit in Patients With Diabetes
Patients with diabetes who stopped taking aspirin three months after the insertion of a coronary stent and then took the anti-platelet medication ticagrelor alone for a year had fewer episodes of bleeding and no increase in heart attacks, stroke or other adverse events caused by blockages in the arteries, compared with patients who took both […]